Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.74K Hold
35
﹤0.01% 297
2026
Q1
$4.42K Hold
35
﹤0.01% 321
2025
Q4
$7.67K Hold
35
﹤0.01% 276
2025
Q3
$4.99K Hold
35
﹤0.01% 309
2025
Q2
$7.11K Hold
35
﹤0.01% 265
2025
Q1
$5.73K Buy
35
+30
+600% +$10.4K ﹤0.01% 273
2024
Q4
$2.03K Hold
5
﹤0.01% 365
2024
Q3
$1.76K Hold
5
﹤0.01% 337
2024
Q2
$1.2K Hold
5
﹤0.01% 343
2024
Q1
$1.43K Hold
5
﹤0.01% 344
2023
Q4
$1.29K Hold
5
﹤0.01% 334
2023
Q3
$1.24K Hold
5
﹤0.01% 354
2023
Q2
$1.66K Sell
5
-13
-72% -$3.4K ﹤0.01% 315
2023
Q1
$4.38K Sell
18
-32
-64% -$9.29K ﹤0.01% 276
2022
Q4
$13K Hold
50
0.01% 212
2022
Q3
$13K Hold
50
0.01% 208
2022
Q2
$11K Buy
50
+10
+25% +$2.97K 0.01% 226
2022
Q1
$14K Hold
40
0.01% 231
2021
Q4
$14K Buy
40
+25
+167% +$15.4K 0.01% 231
2021
Q3
$10K Buy
+15
New +$10.3K 0.01% 244

Other funds holding RH

Kozak & Associates's RH Position: Q2 2026 in Review

Kozak & Associates held its RH (RH) position steady in Q2 2026 at 35 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

Kozak & Associates first reported a position in RH in Q3 2021 and has held it in 20 quarters since. The position peaked at $14K in Q1 2022. 371 funds tracked by Wall St. Rank hold RH as of Q2 2026.

  • Kozak & Associates held 35 shares of RH worth $5.74K as of Q2 2026.
  • Kozak & Associates left its RH share count unchanged in Q2 2026.
  • RH made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #297 holding.
  • Kozak & Associates first reported a position in RH in Q3 2021 and has held it in 20 quarters since.
  • Kozak & Associates's RH position peaked at $14K in Q1 2022.
  • 371 funds tracked by Wall St. Rank held RH as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.